樂心醫療(300562.SZ):手腕式電子血壓計已通過FDA審核並獲得510K號
格隆匯 12 月 8日丨樂心醫療(300562.SZ)公佈,公司於近日收到美國FDA的通知,獲悉公司的手腕式電子血壓計已通過FDA審核並獲得510K號。
手腕式電子血壓計採用示波法通過腕帶傳感器取得的壓力和脈搏信號來自動完成間接測量(無創)動脈血壓的裝置。主機結構包括氣泵、壓力傳感器、放氣閥、電源供應電路、按鍵控制電路、CPU控制模塊、嵌入式軟件。產品的關鍵部件為:壓力傳感器、腕帶、嵌入式軟件(用於血壓監測過程控制、信號特徵提取以及血壓的計算)。測試結果通過藍牙5.0傳輸到手機APP上,該產品小巧、精緻、便攜。
公司致力於針對運動健康、慢病管理等領域為行業客户提供健康IoT和智能健康整體解決方案戰略,上述手腕式電子血壓計的審核通過,將豐富公司產品種類,進一步增強公司產品的綜合競爭力和市場拓展能力,對公司未來的經營將產生積極影響。公司未來會積極推動相關產品的銷售,為廣大股東創造更大的價值。上述產品實際銷售情況取決於未來市場推廣效果,公司目前尚無法預測其對公司未來業績的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.